What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Can Heartworm Be Treated? Options and Success Rates

Name: Can Heartworm Be Treated? Options and Success Rates
Creator: Dr. Zubair Khalid

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-20

Can heartworm be treated? Yes. Canine heartworm disease caused by Dirofilaria immitis is a treatable infection, and the great majority of dogs that complete a properly staged protocol clear their adult worms and survive to discharge [1][2][3]. The treatment is not a single injection or a course of pills. It is a staged medical protocol that begins with confirming the infection, moves through assessing how sick the dog is, and only then delivers an adulticide that kills the worms living in the pulmonary arteries and right side of the heart.

The core of that protocol is melarsomine dihydrochloride, the only adulticidal drug approved by the US Food and Drug Administration for canine heartworm infection [4]. It is combined with a tetracycline antibiotic (usually doxycycline) to weaken the Wolbachia bacteria that live inside the worms, and with a macrocyclic lactone preventive to stop new infections and clear susceptible larval stages [5][6][4]. The American Heartworm Society (AHS) three-dose protocol is the current standard, and it is the protocol against which newer variations are measured [1][3][7].

The total elapsed time from diagnosis to a negative antigen test is typically several months. The hands-on portion (injections, medication courses, rechecks) is concentrated in the first 90 days, but the definitive test of cure happens later, often 6 to 9 months after the last injection [8][9]. Cats are a different story. There is no approved adulticide for feline heartworm infection, so management is supportive and focused on controlling the inflammatory response to dying worms [10].

This article walks through the full decision path: how infection is confirmed, how severity is graded, which protocol fits which patient, what the success rates look like in published studies, what treatment costs, how to manage the risky period after worm death, and how to prevent reinfection once a dog clears the parasite.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

Why Heartworm Treatment Is Staged

Heartworm is not treated the way most bacterial infections are treated, with a drug chosen and given until the organism is gone. The adult worms are large, they live inside blood vessels in the lung, and killing them all at once releases a burst of dead worm material into the pulmonary circulation. That material can obstruct blood flow and trigger severe inflammation. The staging exists to reduce that risk.

Three things have to happen before an adulticide is given. First, the infection has to be confirmed with the right tests, because not every positive screening result means living adult worms are present. Second, the severity of the disease has to be graded, because a dog with mild disease and a dog in heart failure need different levels of caution. Third, the dog has to be started on a macrocyclic lactone and doxycycline, which reduces the Wolbachia burden and the pathology associated with worm death [4][11].

The Wolbachia piece matters more than many owners realize. Wolbachia pipientis is an endosymbiotic bacterium found in all heartworm life stages, and it drives much of the inflammatory response seen in heartworm disease [11]. Doxycycline reduces that bacterial burden. Experimental studies have shown a decrease in gross and microscopic pathology of the lung when dogs are pretreated with doxycycline before melarsomine is given [4]. This is why doxycycline is not optional in a modern protocol. It is part of the standard of care.

Step 1: Confirming the Infection

Diagnosis rests on two tests, and the AHS recommends testing dogs annually for both heartworm antigen and microfilariae [12]. The antigen test detects a protein produced mainly by adult female worms. The microfilaria test (a modified Knott's test or a filter test) detects the circulating offspring of adult worms in the blood.

Both tests have blind spots, which is why they are used together.

A dog with only male worms, or with a very low number of female worms, can test antigen-negative.
A dog with adult worms that are not yet producing microfilariae, or with a single-sex infection, can test microfilaria-negative.
Antigen can be masked by immune complex formation in some dogs, and heat treatment of the serum can unmask it, though heat treatment is not currently recommended by AHS as a routine step [12].

Newer molecular tools exist. Probe-based real-time PCR assays have been designed to detect D. immitis DNA with improved specificity, because earlier PCR protocols cross-reacted with other Dirofilaria species such as Dirofilaria striata [13]. These assays are useful in specific situations but do not replace antigen and microfilaria testing as the first-line diagnostic pair.

A positive result on screening is not the end of the diagnostic process. It is the trigger for the next stage.

Step 2: Grading Severity

Once infection is confirmed, the veterinarian assesses how much damage the worms have already done. This is where radiographs and echocardiography come in.

Thoracic radiographs show the characteristic pulmonary arterial enlargement and the lung changes of heartworm disease. Echocardiography does something radiographs cannot: it can sometimes visualize the worms directly in the pulmonary arteries and right heart, and it estimates parasite burden. In one treatment study, echocardiography was used at diagnosis to assess parasite burden and again later to confirm absence of adult parasites [8]. In another, echocardiography was used to determine the depth of the intramuscular injection site in the lumbar muscles, which is a practical use of ultrasound during treatment [6].

Echocardiography also detects pulmonary hypertension, which is common and serious in heartworm disease. In a study of 34 naturally infected dogs, pulmonary hypertension based on the right pulmonary artery distensibility (RPAD) index was present in 68% of dogs at diagnosis and remained present at day 120 after the adulticide protocol [14]. That study found no worsening of pulmonary hypertension after worm elimination, regardless of parasite burden, but it also noted that the death of the worms during treatment causes thromboembolism and tends to worsen vascular damage and pulmonary hypertension in the short term [14]. This is a key point for owners: the treatment itself is the riskiest period, not the period before treatment.

The severity grading that comes out of this assessment determines which protocol is appropriate and how much monitoring the dog needs.

Step 3: The Adulticide Protocol

The AHS-recommended protocol combines three components: a monthly macrocyclic lactone, a 28-day course of doxycycline at 10 mg/kg twice daily, and the three-dose melarsomine regimen [5]. Melarsomine is given at 2.5 mg/kg by intramuscular injection [5][15].

The three-dose protocol is structured as one injection, then a pause of roughly one month, then two injections given 24 hours apart [15][6]. The rationale for the split is tolerability. The first injection kills a portion of the worms. The month-long gap lets the dog recover from that first wave of worm death before the second and third injections deliver the larger kill. This is why the three-dose protocol is considered safer for dogs with more severe disease, and why it is the standard rather than a single large dose.

The Two-Dose Alternative

A two-dose protocol exists and has been revisited in the era of adjunctive therapy. In a retrospective comparison of 1,246 shelter dogs with class 1 and 2 heartworm disease, all of which received a macrocyclic lactone and doxycycline, follow-up antigen tests were negative in 242 of 252 dogs (96.0%) in the two-dose group and 24 of 24 dogs (100%) in the three-dose group [7]. The difference was not statistically significant. All-cause mortality was 0.8% in the two-dose group and 2.6% in the three-dose group, also not statistically significant, but heartworm-related mortality was 0.2% in the two-dose group versus 2.6% in the three-dose group, which was significant [7].

A randomized clinical trial then compared compressed two-dose and three-dose protocols in 168 dogs with class 1 or 2 disease. All dogs received sustained-release moxidectin, doxycycline, and prednisone. The two-dose group received melarsomine on days 14 and 15. The three-dose group received it on days 14, 44, and 45. Efficacy was 95.3% in the two-dose group and 98.8% in the three-dose group, with no significant difference, and survival was 100% in both groups [9]. The trial authors noted that the sample size was insufficient for a conclusive noninferiority analysis at their predefined margin, so the two-dose protocol is best understood as a reasonable option for mild disease rather than a proven equivalent for every case [9].

The practical distinction is this: the two-dose protocol compresses treatment into a shorter window and may suit dogs with class 1 or 2 disease, while the three-dose protocol remains the standard for dogs with more severe disease or higher parasite burdens.

Protocol Variations and Timing

Researchers have tested whether the protocol can be shortened without losing safety or efficacy. One study evaluated a variation in which macrocyclic lactones (ivermectin) were given for a single month before the first melarsomine dose, with doxycycline for 30 days, and melarsomine on days 30, 60, and 61. Six months after the last dose, all 76 dogs were antigen-negative and amicrofilaremic, and 38.1% of the dogs evaluated by echocardiography showed no adult parasites [8]. The authors reasoned that pre-administration of macrocyclic lactones avoids the ineffectiveness of melarsomine against worms younger than 4 months [8].

A shelter study compared the AHS protocol, which starts the first melarsomine injection around day 60, against a modified protocol starting around day 14. Among 157 dogs with asymptomatic or mild disease, all survived to discharge, and there was no statistically significant difference in new respiratory signs after melarsomine between the group treated at day 14 and the group treated at day 60 [1]. That study also compared once-daily versus twice-daily doxycycline and found no significant difference in new respiratory or gastrointestinal signs between the two dosing schedules [1].

A separate study of the AHS protocol in 44 dogs used moxidectin instead of ivermectin and applied ultrasound guidance for the melarsomine injections. Microfilaremic dogs were pretreated with prednisolone and clopidogrel for one week before the first moxidectin application. Moxidectin was applied on days 1, 30, 60, and 90. Doxycycline at 10 mg/kg twice daily was given for days 1 through 28. Melarsomine was given on days 60, 90, and 91. From day 60, dalteparin was applied for 10 days to reduce the chance of pulmonary thromboembolism. Moxidectin caused no adverse reactions, even in microfilaremic dogs, and gastrointestinal side effects of doxycycline occurred in 3 of 44 dogs (6%), all of which recovered with symptomatic therapy [6].

Doxycycline: Dose and Alternatives

The standard doxycycline dose is 10 mg/kg twice daily for 28 to 30 days [5][11]. A study comparing 10 mg/kg and 5 mg/kg twice daily for 30 days in 77 naturally infected dogs found that both regimens significantly reduced C-reactive protein concentrations from baseline, indicating that the lower dose still produced a measurable anti-inflammatory effect [11]. That said, the 10 mg/kg twice-daily dose remains the recommended standard.

Minocycline has been evaluated as an alternative to doxycycline because of price increases and decreasing availability of doxycycline. In a study of 32 heartworm-positive dogs, dogs received 10 mg/kg or 5 mg/kg of either doxycycline or minocycline twice daily for 28 days, alongside six months of ivermectin/pyrantel and the three-dose melarsomine protocol. A greater number of dogs in the 10 mg/kg doxycycline and minocycline groups experienced gastrointestinal side effects compared with the 5 mg/kg groups [5]. This is a reminder that higher antibiotic doses carry more GI risk.

The Moxi-Doxy Alternative When Melarsomine Is Not Available

Melarsomine is not available in every country, and it is inaccessible to some owners and shelters because of cost [16]. For those situations, a non-arsenical protocol using moxidectin and doxycycline (often called moxi-doxy) provides a viable alternative to no treatment at all [16].

The most effective non-arsenical regimen described in the literature is doxycycline at 10 mg/kg orally every 12 or 24 hours for 28 days, combined with topical moxidectin at the label dose. Moxidectin is repeated monthly until a no-antigen-detected (NAD) status is confirmed. In moxi-doxy protocols, doxycycline should be repeated annually until NAD [16].

A systematic review and meta-analysis of 14 studies involving 358 dogs, primarily with stage 1 to 2 heartworm disease, found a time-dependent adulticidal effect of moxi-doxy. In comparative studies, antigen-negative conversion rates were similar to those of melarsomine from 9 months onward, with the highest certainty of evidence at 18 months [17]. The tradeoff is time. Moxi-doxy works more slowly than melarsomine, and the dog remains infected for longer, which means a longer period of exercise restriction and monitoring.

Moxi-doxy is not a first-choice protocol when melarsomine is available. It is a fallback that is far better than leaving the infection untreated.

Exercise Restriction and the Thromboembolism Risk

Pulmonary thromboembolism is an inevitable consequence of worm death [4]. When adult worms die, their bodies are carried into the pulmonary arteries, where they can obstruct blood flow and provoke inflammation. This is the single most dangerous part of heartworm treatment, and it is the reason exercise restriction is not optional.

Exercise increases cardiac output and pulmonary blood flow, which pushes more dead worm material into the lungs and raises the risk of a severe reaction. Dogs are typically restricted during the treatment period and for a period afterward. In the randomized trial comparing two-dose and three-dose protocols, dogs were exercise restricted for four weeks following melarsomine [9]. In a high-volume outpatient protocol, the exercise restriction period was reduced relative to standard recommendations, and the authors reported that 539 of 556 dogs (97%) completed the three-injection series and no microfilariae were detected in 99% (428 of 433) of those who returned for post-injection microfilaria testing [18].

The clinical signs to watch for during the restriction period are coughing, increased respiratory effort, and lethargy. In the randomized trial, complications were rare, with 7 dogs requiring thoracic radiographs with or without additional treatment, but none requiring intensive management [9]. In an earlier case series of 50 dogs treated with the AHS protocol, 26 dogs (52%) experienced minor complications such as injection site reactions, gastrointestinal signs, and behavioral changes, and 27 dogs (54%) experienced respiratory signs attributed to progressive heartworm disease and worm death. Seven dogs (14%) died within the treatment period [15]. That series reflects a population that included more severely affected dogs, and it underscores why severity grading matters.

Inflammatory and hemostatic markers change measurably during treatment. A study of 12 dogs found that serum levels of D-dimer, interleukin-6, C-reactive protein, and cardiac troponin I differed significantly at time points after melarsomine treatment and also differed by disease stage [19]. This is laboratory confirmation of what the clinical picture shows: the post-injection period is an active inflammatory and clotting event, not a quiet recovery.

Cats: No Approved Adulticide

Cats respond to heartworm infection very differently from dogs, and the treatment options are correspondingly different. There is no approved adulticidal drug for feline heartworm infection, so management is supportive [10]. The goal is to control the clinical signs and the inflammatory response to dying worms, not to kill the adult worms directly with an adulticide.

This is a critical distinction for cat owners. A cat diagnosed with heartworm cannot be treated the way a dog is treated. The veterinarian manages symptoms, monitors for complications, and relies on the worms' natural lifespan, which is shorter in cats than in dogs, to resolve the infection over time. Any specific medication decision for a cat is an individual case for the veterinarian.

Decision Flow

The following diagram shows the main decision path from a positive heartworm test to a treatment choice.

flowchart TD
    A[Positive heartworm test] --> B[Confirm with antigen and microfilaria tests]
    B --> C[Grade severity with radiographs and echocardiography]
    C --> D{Class 1 or 2 mild disease}
    D -->|Yes| E[Consider two dose melarsomine]
    D -->|No| F[Use three dose melarsomine]
    E --> G[Add doxycycline and macrocyclic lactone]
    F --> G
    G --> H[Restrict exercise during and after treatment]
    H --> I[Recheck antigen 6 to 9 months later]
    I --> J{Negative result}
    J -->|Yes| K[Start prevention and retest annually]
    J -->|No| L[Discuss further testing with veterinarian]

Success Rates and Prognosis

The published success rates for melarsomine-based protocols are high, particularly in dogs with mild to moderate disease.

Protocol	Typical cost range	Reported success rate	Prognosis
Three-dose melarsomine with doxycycline and macrocyclic lactone	Not established in reviewed sources	100% antigen-negative in one small cohort [7], 98.8% in a randomized trial [9]	Good to excellent in class 1 to 2 disease, guarded in severe disease
Two-dose melarsomine with doxycycline and macrocyclic lactone	Not established in reviewed sources	96.0% antigen-negative [7], 95.3% in a randomized trial [9]	Good in class 1 to 2 disease
Moxi-doxy non-arsenical	Not established in reviewed sources	Antigen-negative conversion similar to melarsomine from 9 months onward [17]	Reasonable when melarsomine is unavailable, slower to clear
Supportive management only (cats)	Not established in reviewed sources	No approved adulticide [10]	Variable, depends on individual case

Cost figures vary widely by region, clinic, and case complexity. The reviewed studies do not provide a reliable cost range that would apply to a typical US practice, so no dollar figures are given here. Owners should request an itemized estimate from their veterinarian.

The prognosis depends heavily on disease stage at diagnosis. Dogs with class 1 or class 2 disease generally do well. In the German referral center study of 283 dogs with class I to III disease treated with the AHS/ESDA protocol, all dogs received 28 days of doxycycline and monthly macrocyclic lactones followed by the three-dose melarsomine protocol, with supportive care including sedation, intravenous fluids, and maropitant as clinically indicated [2]. That study is a useful reference for what a real-world referral population looks like and how the protocol is delivered in practice.

Pulmonary hypertension is a major determinant of outcome. Because it was present in 68% of dogs at diagnosis in one study and persisted at day 120 even after worm elimination [14], owners should understand that clearing the worms does not instantly restore normal lung vasculature. The vascular changes can take time to improve, and in some dogs they do not fully resolve.

What to Expect During Treatment

A typical treatment course involves several distinct phases.

Pretreatment phase. Doxycycline for 28 to 30 days, plus a macrocyclic lactone. This phase reduces the Wolbachia burden and the pathology associated with worm death [4][11].
First melarsomine injection. Given intramuscularly, often with sedation and pain medication. Ice at the injection site is used in some protocols [3].
Rest period. Roughly one month between the first injection and the second and third injections in the three-dose protocol [15].
Second and third injections. Given 24 hours apart [15].
Post-treatment restriction. Exercise restriction continues for weeks after the last injection [9].
Recheck. Antigen testing 6 to 9 months after the last melarsomine injection to confirm cure [9].

Supportive care during treatment can include sedation for injections, intravenous fluids, maropitant for nausea, and additional medications as clinically indicated [2]. In one protocol, microfilaremic dogs received prednisolone and clopidogrel for one week before the first moxidectin application, and dalteparin was used for 10 days from day 60 to reduce the chance of pulmonary thromboembolism [6].

Gastrointestinal side effects from doxycycline are common enough to plan for. In one study, 6% of dogs experienced GI side effects that resolved with symptomatic therapy [6]. Probiotics are sometimes given alongside doxycycline [6].

Prevention After Recovery

Treatment does not create immunity. A dog that clears heartworm infection can be reinfected by a new mosquito bite the same season. Prevention after recovery is not optional.

The macrocyclic lactone used during treatment also serves as the preventive going forward. In the moxi-doxy protocol, moxidectin is repeated monthly until NAD is confirmed, and doxycycline is repeated annually until NAD [16]. In melarsomine protocols, the macrocyclic lactone is continued monthly [5][6].

There is a complication that owners should know about. Macrocyclic lactone resistance has been documented in D. immitis isolates, with genotypically and phenotypically confirmed resistant isolates found in the Lower Mississippi River Valley region of the United States [20]. A surveillance study of 310 microfilaremic blood samples from 45 clinics in 22 states used a two-SNP model to identify genotypically susceptible, mixed, and resistant populations [20]. This means that in some regions, the preventive that worked for decades may not fully protect a dog. Annual testing remains essential even in dogs on year-round prevention, because a negative test is the only way to know the preventive is working.

Doxycycline also has a transmission-blocking effect. A study in microfilaremic Beagles found that doxycycline at various dosages and schedules, combined with a single prophylactic dose of ivermectin, affected the ability of infective larvae from mosquitoes to develop normally in recipient dogs [21]. This is one more reason doxycycline is embedded in the protocol rather than added as an afterthought.

Limitations and When to Contact a Veterinarian

Every case is individual, and the protocols described here are the published standards, not a prescription for a specific dog. A veterinarian who has examined the dog, reviewed the radiographs and echocardiogram, and knows the dog's full medical history is the only one who can choose the right protocol and timing.

Contact a veterinarian promptly if any of the following occur during or after treatment:

Coughing that is new, worsening, or accompanied by increased respiratory effort
Difficulty breathing at rest or during minimal activity
Collapse, fainting, or sudden weakness
Lethargy or depression that is more than mild
Vomiting, diarrhea, or refusal to eat that lasts more than a day
Swelling, pain, or discharge at an injection site
Any sign that the dog is not tolerating exercise restriction

These signs can indicate pulmonary thromboembolism, a severe inflammatory reaction, or another complication that needs immediate assessment [14][4][15].

Frequently Asked Questions

Can heartworm be treated in dogs?

Yes. Canine heartworm infection is treatable with a staged protocol built around melarsomine, doxycycline, and a macrocyclic lactone [5][6][4]. The great majority of dogs that complete treatment survive to discharge and clear the infection [1][2][3].

Can heartworms be treated without melarsomine?

Yes, in situations where melarsomine is unavailable or inaccessible. A moxi-doxy protocol using topical moxidectin and oral doxycycline can kill adult heartworms over a longer period, with antigen-negative conversion rates similar to melarsomine from 9 months onward [17][16].

What is the difference between the two-dose and three-dose melarsomine protocols?

The three-dose protocol gives one injection, then two more injections 24 hours apart about a month later [15]. The two-dose protocol compresses treatment into a shorter window and is generally reserved for dogs with class 1 or 2 disease [9].

How long does heartworm treatment take?

The hands-on portion is concentrated in the first 90 days, but the definitive test of cure happens 6 to 9 months after the last melarsomine injection [9]. Moxi-doxy protocols take longer, with the highest certainty of antigen-negative conversion at 18 months [17].

Why is exercise restriction so important during treatment?

Exercise increases pulmonary blood flow and pushes more dead worm material into the lungs, raising the risk of thromboembolism [4]. Restriction is typically continued for weeks after the last injection [9].

Can cats with heartworm be treated with an adulticide?

No. There is no approved adulticidal drug for feline heartworm infection, so management is supportive and focused on controlling clinical signs [10].

What happens if heartworm treatment fails?

A positive antigen test after the expected clearance window means the infection was not fully eliminated. This can happen with reinfection, resistant worms, or incomplete treatment, and it requires further diagnostic testing and a new treatment plan discussed with a veterinarian [20].

Can a dog get heartworm again after treatment?

Yes. Treatment does not create immunity, and a dog can be reinfected by a new mosquito bite. Monthly macrocyclic lactone prevention and annual testing are essential after recovery [16][12][20].